When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Deciphera Pharmaceuticals: Updates To Thesis Expecting A Rebound Ahead Of August PDUFA
Deciphera Pharmaceuticals Inc.
Shares of Deciphera Pharmaceuticals (DCPH) have risen by 20% since my August 2019 update called the stock a Buy based on ripretinib's impressive showing in fourth-line and fourth-line plus gastrointestinal stromal tumors (GIST). Targeted oncology has been one of my favored themes to capitalize on in the past and it seemed that expansion potential of this lead drug candidate compounded with potential of pipeline assets was indicative of significant undervaluation.
As the share price took a hit to start 2020 and the company has a key regulatory date approaching in Q3, I feel